Industry Update: Pharmaceuticals

Industry Highlights

  • On February 24, 2023, AstraZeneca announced the successful completion of the acquisition of CinCor Pharma, Inc., a US-based clinical-stage biopharmaceutical company, focused on developing novel treatments for resistant and uncontrolled hypertension as well as chronic kidney disease, for approximately $1.6 billion.
  • On December 1, 2022, Eli Lilly and Company announced the successful completion of its $625 million acquisition of Akouos, Inc. The acquisition expands Lilly’s efforts in genetic medicines to include Akouos’s portfolio of potential first-in-class adeno-associated viral gene therapies for the treatment of inner ear conditions.

Past Industry Updates

Pharmaceuticals: November 2022

Pharmaceuticals: August 2022

Pharmaceuticals: April 2022

Pharmaceuticals: February 2022

More Industry Reports